Industry leader in the development of CAD and image analysis software selects clinivation’s Global Market Clearance Services to position their operations for continued growth and successful expansion.
Natick, MA, October 3, 2008 – clinivation, Inc. announced today that MedicSight has selected clinivation’s Global Market Clearance Services.
“MedicSight is a world leader in the development of CAD and image analysis software for the medical community, and we are pleased that they have selected clinivation’s Global Market Clearance Services to position their operations for continued growth and successful expansion,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About clinivation’s Global Market Clearance Services
Clinivation’s Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.
MedicSight is an industry leader in the development of enterprise-wide computer-aided detection (CAD) software for use by the medical imaging community to aid in earlier detection of disease. MedicSight’s patented software solutions have been validated against one of the world’s largest and most population-diverse databases of verified CT scan data to help clinicians confidently identify, measure, and analyze suspicious pathology on CT scans of the colon and lung.
The company’s CAD products include ColonCAD™ for CT colonography and LungCAD™ for CT scans of the thorax. Both products integrate with advanced visualization software. This feature allows clinical end users to perform either a ‘second read’ where CAD findings are displayed to the user after completion of an initial review of the CT scan data, or a ‘concurrent read’ where CAD findings are available to the end user during their initial review of the CT scan images, providing a CAD solution that can be matched to individual workflow requirements and productivity.
Headquartered in London, Medicsight is a subsidiary of MGT Capital Investments, Inc.
About MGT Capital Investments, Inc.
MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The company has two subsidiaries, Medicsight and Medicexchange.
For more information please visit www.mgtci.com.